Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phenotypic Personalized Medicine: Systematically Optimized Combination Therapy in Multiple Myeloma Using CURATE.AI

NCT03759093 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT03759093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03759093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phenotypic Personalized Medicine: Systematically Optimized Combination Therapy in Multiple Myeloma Using CURATE.AI
Lead sponsor
National University Hospital, Singapore
Phase
Phase 2/3
Overall status
Unknown status
Start date
September 10, 2023
Completion date
September 10, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma